# SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

> **NCT00003223** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 5 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** fenretinide

## Key facts

- **NCT ID:** NCT00003223
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-12
- **Primary completion:** 2000-03
- **Final completion:** 2000-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Closed due to poor accrual.
- **Last updated:** 2012-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003223, "SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*